Topical Insights Into the Post-Approval Controversies of Aducanumab. Alzforum, 11 Dec 2021 Kumar D, Yadav DK, Hassan MI. Front Pharmacol. 2021;12:787303. Epub 2021 Nov 18 PubMed.